Eisman, J. A. , Bogoch, E. R. , Dell, R. , Harrington, J. T. , Mckinney, R. E. , & Mclellan, A. , et al. (2012). Making the first fracture the last fracture: asbmr task force report on secondary fracture prevention. Journal of Bone & Mineral Research, 27(10), 2039-2046.
 Black, D. M. , & Rosen, C. J. . (2016). Clinical practice. Postmenopausal osteoporosis.
 Zebaze, R. M. , Libanati, C. , Austin, M. , Ghasem-Zadeh, A. , & Seeman, E. . (2013). Differing effects of denosumab and alendronate on cortical and trabecular bone. Bone, 59(2), 173-179.
 Oswald, A. J. , Berg, J. , Milne, G. , & Ralston, S. H. . (2014). Teriparatide treatment of severe osteoporosis reduces the risk of vertebral fractures compared with standard care in routine clinical practice. Calcified Tissue International, 94(2), 176.
 Walsh, J. B. , Lems, W. F. , Karras, D. , Langdahl, B. L. , Ljunggren, O. , & Fahrleitner-Pammer, A. , et al. (2012). Effectiveness of teriparatide in women over 75 years of age with severe osteoporosis: 36-month results from the european forsteo observational study (efos). Calcif Tissue Int, 90(5), 373-383.
 Adler, & Robert, A. . (2018). Update on Osteoporosis in Men.
 Tanaka, I. , Tanaka, Y. , Soen, S. , & Oshima, H. . (2020). Efficacy of once-weekly teriparatide in patients with glucocorticoid-induced osteoporosis: the tower-go study. Journal of Bone and Mineral Metabolism, 1-10.
 Huang, S. , Lin, H. , Zhu, X. , Chen, X. , Fan, L. , & Liu, C. . (2014). Zoledronic acid increases bone mineral density and improves health-related quality of life over two years of treatment in chinese women with postmenopausal osteoporosis. Endokrynologia Polska, 65(2), 96-104.
 Maricic, M. . (2010). The role of zoledronic acid in the management of osteoporosis. Clinical Rheumatology, 29(10), 1079-1084.
 Dhillon, S. . (2016). Zoledronic acid (reclast®, aclasta®): a review in osteoporosis. Drugs.
 John, M. T. , Sims, N. A. , & Ego, S. . (2021). Physiological and pharmacological roles of pth and pthrp in bone using their shared receptor, pth1r. Endocrine Reviews.
 Kim SW, Pajevic PD, Selig M, Barry KJ, Y ang JY , Shin CS, Baek WY , Kim JE, Kronenberg HM. . (2012). Intermittent parathyroid hormone administration converts quiescent lining cells to active osteoblasts. Journal of Bone and Mineral Research, 27(10).
 Bellido T, Ali AA, Plotkin LI, Fu Q, Gubrij I, Roberson PK, Weinstein RS, O'Brien CA, Manolagas SC, Jilka RL. .(2003). Proteasomal degradation of runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. a putative explanation for why intermittent administration is needed for bone anabolism. Journal of Biological Chemistry, 278(50), 50259-72.
 Zhang, W. , Zhu, J. , Ma, T. , Liu, C. , Hai, B. , & Du, G. , et al. (2017). Comparison of the effects of once‐weekly and once‐daily rhpth (1–34) injections on promoting fracture healing in rodents. Journal of Orthopaedic Research.
 Rowshan, H. H. , Parham, M. A. , Baur, D. A. , Mcentee, R. , Cauley, E. , & Carriere, D. T. , et al. (2010). Effect of intermittent systemic administration of recombinant parathyroid hormone (1-34) on mandibular fracture healing in rats. J Oral Maxillofac Surg, 68(2), 260-267.
 A, M. K. , A, E. K. S. , B, C. W. , C, M. W. , A, L. K. , & A, S. S. , et al. (2010). Effect of human parathyroid hormone hpth (1–34) applied at different regimes on fracture healing and muscle in ovariectomized and healthy rats. Bone, 47( 3), 480-492.
 Seeman, E. , & Martin, T. J. . (2015). Co-administration of antiresorptive and anabolic agents: a missed opportunity. Journal of Bone & Mineral Research the Official Journal of the American Society for Bone & Mineral Research, 30(5), 753-764.
 Liu, Z. D. , Tao, J. C. , Yi, X. , & Zhang, C. Y. . (2009). Associations of age-related expression changes of peroxisome proliferator-activated receptor gamma and core binding factor alpha 1 in bone marrow cells with age-related fracture healing impairment in rats. Journal of Clinical Rehabilitative Tissue Engineering Research.
Vandenbroucke, F P, Luyten, Flamaing, & Gielen. (2017). Pharmacological treatment of osteoporosis in the oldest old. Clinical interventions in aging.
 Dempster, D. W. , Roschger, P. , Misof, B. M. , Zhou, H. , Paschalis, E. P. , & Alam, J. , et al. (2016). Differential effects of teriparatide and zoledronic acid on bone mineralization density distribution at 6 and 24 months in the shotz study. Journal of Bone & Mineral Research the Official Journal of the American Society for Bone & Mineral Research, 1527-1535.
 Wei, Y. , Miao, Y. , & Liu, Z. . (2007). Clinical progress in biochemical markers for bone metabolism—review in biochemical markers for bone metabolism in different countries and regions in premenopausal and postmenopausal women. Chinese Journal of Osteoporosis.
 Kyvernitakis, I. , Saeger, U. , Ziller, V. , Bauer, T. , Seker-Pektas, B. , & Hadji, P. . (2013). The effect of age, sex hormones, and bone turnover markers on calcaneal quantitative ultrasonometry in healthy german men. Journal of Clinical Densitometry, 16(3), 320-328.
 Shi, Z. , Jin, H. , Ding, Q. , Ying, J. , & He, B. . (2019). Bone turnover markers may predict the progression of osteonecrosis of the femoral head in aged males. Annals of Translational Medicine, 7(22), 626-626.
 Prince, R. , Sipos, A. , Hossain, A. , Syversen, U. , Ish-Shalom, S. , & Marcinowska, E. , et al. (2010). Sustained nonvertebral fragility fracture risk reduction after discontinuation of teriparatide treatment. Journal of Bone and Mineral Research, 20(9), 1507-1513.
 Hadji, P. , Zanchetta, J. R. , Russo, L. , Recknor, C. P. , Saag, K. G. , & Mckiernan, F. E. , et al. (2012). The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures. Osteoporosis International, 23(8), 2141-2150.
 Ito, A. , Iimura, T. , Lee, J. W. , Shimazu, Y. , & Takao-Kawabata, R. . (2020). Teriparatide relieves ovariectomyinduced hyperalgesia in rats, suggesting the involvement of functional regulation in primary sensory neurons by pth-mediated signaling. Scientific Reports, 10(1), 5346.
 A. J. Roelofs, K. Thompson, F. H. Ebetino, M. J. Rogers, F. P. Coxon. (2010). Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages. Current Pharmaceutical Design, 16(27), -.
 Baron, R. , Fe Rrari, S. , & Russell, R. . (2011). Denosumab and bisphosphonates: different mechanisms of action and effects. Bone, 48(4), 0-692.
 Cai, G. , Laslett, L. L. , Aitken, D. , Halliday, A. , Pan, F. , & Otahal, P. , et al. (2018). Effect of zoledronic acid and denosumab in patients with low back pain and modic change: a proof‐of‐principle trial. Journal of Bone & Mineral Research.
Tan Jinmei，Bao Lihua，Ma Yuwei，et al. (2010). The comparison of the clinical outcomes between parathyroid hormone and calcitonin in short-term treatment of postmenopausal osteoporosis. Acta UnivMed Nanjing, 30(5):709-712